DZ Bank’s Gilead Sciences GILD Stock Holding History

DZ Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-100	Closed	-$7K	–	892
2017 Q2	$7K	Buy	+100	New	+$6.65K	﹤0.01%	915

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

DZ Bank's GILD Position: Q1 2026 in Review

DZ Bank increased its Gilead Sciences (GILD) stake by 3.9% in Q1 2026, buying an estimated $11.2M and bringing the position to 2,122,979 shares worth $296M. The position accounts for 0.26% of the portfolio, ranked #83.

DZ Bank first reported a position in GILD in Q4 2016 and has held it in 38 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

DZ Bank held 2,122,979 shares of Gilead Sciences worth $296M as of Q1 2026.
DZ Bank bought 80,154 Gilead Sciences shares in Q1 2026, an estimated $11.2M.
Gilead Sciences made up 0.26% of DZ Bank's portfolio in Q1 2026, its #83 holding.
DZ Bank first reported a position in Gilead Sciences in Q4 2016 and has held it in 38 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.